Browse studies
Find your next paid study
3 recruiting studies matching your filters
Phase 2
Development of FAPI PET as a Non-invasive Biomarker of Pulmonary Fibrogenesis
The goal of this clinical trial is to gain more information about how fibroblast activation protein inhibitor (FAPI) binds to a certain type of cells in fibrot…
Fibrosis Lung
University of Wisconsin, MadisonNCT06940427
Phase 1
A Double-Blind, Active-Controlled, Multiple-Ascending Dose, Phase 1b/2a Study of Aerosolized RSP-1502 Delivered Via the PARI LC Plus® Nebulizer in Subjects With Cystic Fibrosis and Chronic Pseudomonas Aeruginosa Lung Infection
A double-blind, active-controlled, multiple-ascending dose, safety study of aerosolized RSP-1502 in subjects with cystic fibrosis Pseudomonas aeruginosa lung i…
Cystic Fibrosis LungRespiratory Infections, Recurrent, ChronicPseudomonas Aeruginosa
Respirion Pharmaceuticals Pty LtdNCT06016088
Phase 2
An Open-label, Phase 1/2 Trial of Gene Therapy 4D-710 in Adults With Cystic Fibrosis
This is a Phase 1/2 multicenter, open-label, single dose trial of 4D-710 investigational gene therapy in adults with cystic fibrosis.
Cystic Fibrosis Lung
4D Molecular TherapeuticsNCT05248230